110 related articles for article (PubMed ID: 32194704)
1. Erratum: A combination of inhibitors of glycolysis, glutaminolysis and
Schcolnik-Cabrera A; Dominguez-Gómez G; Chávez-Blanco A; Ramírez-Yautentzi M; Morales-Bárcenas R; Díaz-Chávez J; Taja-Chayeb L; Dueñas-González A
Oncol Lett; 2020 Mar; 19(3):2071. PubMed ID: 32194704
[TBL] [Abstract][Full Text] [Related]
2. A combination of inhibitors of glycolysis, glutaminolysis and
Schcolnik-Cabrera A; Dominguez-Gómez G; Chávez-Blanco A; Ramírez-Yautentzi M; Morales-Bárcenas R; Chávez-Díaz J; Taja-Chayeb L; Dueáas-González A
Oncol Lett; 2019 Dec; 18(6):6909-6916. PubMed ID: 31788130
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids.
Cervantes-Madrid D; Dueñas-González A
Oncol Rep; 2015 Sep; 34(3):1533-42. PubMed ID: 26134042
[TBL] [Abstract][Full Text] [Related]
4. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
5. The combination of orlistat, lonidamine and 6-diazo-5-oxo-L-norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells.
Schcolnik-Cabrera A; Chavez-Blanco A; Dominguez-Gomez G; Juarez M; Lai D; Hua S; Tovar AR; Diaz-Chavez J; Duenas-Gonzalez A
Oncol Lett; 2020 Sep; 20(3):3053-3060. PubMed ID: 32782623
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and antitumor efficacy
Cervantes-Madrid D; Dominguez-Gomez G; Gonzalez-Fierro A; Perez-Cardenas E; Taja-Chayeb L; Trejo-Becerril C; Duenas-Gonzalez A
Oncol Lett; 2017 Mar; 13(3):1905-1910. PubMed ID: 28454342
[TBL] [Abstract][Full Text] [Related]
7. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation.
Araujo L; Khim P; Mkhikian H; Mortales CL; Demetriou M
Elife; 2017 Jan; 6():. PubMed ID: 28059703
[TBL] [Abstract][Full Text] [Related]
8. Effect of PTEN loss on metabolic reprogramming in prostate cancer cells.
Zhou X; Yang X; Sun X; Xu X; Li X; Guo Y; Wang J; Li X; Yao L; Wang H; Shen L
Oncol Lett; 2019 Mar; 17(3):2856-2866. PubMed ID: 30854061
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer.
Akins NS; Nielson TC; Le HV
Curr Top Med Chem; 2018; 18(6):494-504. PubMed ID: 29788892
[TBL] [Abstract][Full Text] [Related]
10. Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer.
Song Z; Wei B; Lu C; Li P; Chen L
Oncol Lett; 2017 Sep; 14(3):3117-3123. PubMed ID: 28928849
[TBL] [Abstract][Full Text] [Related]
11. Glutaminolysis and glycolysis regulation by troglitazone in breast cancer cells: Relationship to mitochondrial membrane potential.
Friday E; Oliver R; Welbourne T; Turturro F
J Cell Physiol; 2011 Feb; 226(2):511-9. PubMed ID: 20683912
[TBL] [Abstract][Full Text] [Related]
12. Erratum.
Sci Technol Adv Mater; 2016; 17(1):188. PubMed ID: 27889790
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Molecular heterogeneity of guanine nucleotide binding-protein γ subunit 4 in left- and right-sided colon cancer.
Song J; Yang J; Lin R; Cai X; Zheng L; Chen Y
Oncol Lett; 2021 Mar; 21(3):227. PubMed ID: 33613716
[TBL] [Abstract][Full Text] [Related]
14. Erratum to:
Pilot and Feasibility Studies
Pilot Feasibility Stud; 2017; 3():48. PubMed ID: 29123916
[TBL] [Abstract][Full Text] [Related]
15. Erratum for
Spinal Cord Ser Cases; 2016; 2():16019. PubMed ID: 31265710
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Publisher Correction to: Multiple articles in Food Science and Biotechnology.
Publisher
Food Sci Biotechnol; 2018 Aug; 27(4):1245. PubMed ID: 30265261
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Publisher Correction: articles initially published in wrong volume.
Cell Death Discov; 2019; 5():116. PubMed ID: 31312525
[TBL] [Abstract][Full Text] [Related]
18. Erratum: Molecular heterogeneity of guanine nucleotide binding-protein γ subunit 4 in left- and right-sided colon cancer.
Song J; Yang J; Lin R; Cai X; Zheng L; Chen Y
Oncol Lett; 2023 Jan; 25(1):11. PubMed ID: 36478907
[TBL] [Abstract][Full Text] [Related]
19. Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism.
Ni T; He Z; Dai Y; Yao J; Guo Q; Wei L
Cell Death Dis; 2017 Jun; 8(6):e2865. PubMed ID: 28594405
[TBL] [Abstract][Full Text] [Related]
20. N-Myc downstream-regulated gene 2 restrains glycolysis and glutaminolysis in clear cell renal cell carcinoma.
Shi W; Xu X; Yan F; Wang B; Zhao H; Chan A; Ren Z; Ma Y; Wang F; Yuan J
Oncol Lett; 2017 Dec; 14(6):6881-6887. PubMed ID: 29163707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
